Isogenis is focused upon novel immune modulating therapeutics for the treatment of immune disorders, genetic diseases, and transplant tolerance. A number of animal veto effect exploitation model transplantation systems have been developed for: pancreatic islet, liver, and heart transplantations, and have subsequently validated that their approaches have permanently protected tissues from rejection. Current foci of [...]